| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |